Nuss John's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Apr 5, 2023
- Accession no.
- 0001209191-23-023470
- Filed
- Apr 5, 2023, 7:13 PM ET
- Trade date
- Apr 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $986.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nuss JohnCIK 0001874108 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $0.20 | +$6,000 | 274,815 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −29,900 | $32.87F2 | −$982,875.79 | 244,915 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −100 | $33.57 | −$3,357 | 244,815 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 66,778 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 29,900 shares sold in the price range of $32.56 to $33.49. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.